Anton Gueth is Director at ANTARES PHARMA, INC. (AIS). They have made 6 open-market trades across 2 companies since 2009, most recently 2022-05-24.
CIK 0001274940
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
4 open-market purchases totalling $58K since 2009, against 2 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ATRS | SELL | 2021-07-08 | 2021-07-09 | $4.29 | $429K | +1.5% | -7.4% | -21.0% |
| ATRS | BUY | 2016-03-18 | 2016-03-21 | $0.72 | $36K | +10.9% | +8.3% | +25.6% |
| ATRS | BUY | 2014-08-11 | 2014-08-13 | $2.00 | $10K | -22.0% | -2.5% | -2.5% |
| ATRS | SELL · 10b5-1 | 2013-09-03 | 2013-09-05 | $4.42 | $111K | -22.0% | -2.5% | -2.5% |
| ATRS | SELL · 10b5-1 | 2013-08-01 | 2013-08-05 | $4.41 | $110K | -22.0% | -2.5% | -2.5% |
| ATRS | SELL · 10b5-1 | 2013-07-01 | 2013-07-03 | $4.15 | $104K | -22.0% | -2.5% | -2.5% |
| ATRS | SELL · 10b5-1 | 2013-06-03 | 2013-06-05 | $4.01 | $100K | -22.0% | -2.5% | -2.5% |
| AIS | SELL | 2012-05-30 | 2012-05-31 | $2.85 | $249K | N/A | N/A | N/A |
| AIS | BUY | 2010-09-27 | 2010-09-28 | $1.41 | $11K | N/A | N/A | N/A |
| AIS | BUY | 2009-05-15 | 2009-05-18 | $0.60 | $600 | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.